You are here: Industry Insights > COVID-19

News List

Side Effects Seen With Use of Chloroquine Against COVID-19 Drugs.com
April 08, 2020
The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision.
Limited supply of antimalarial drugs may prevent use against COVID-19, say doctors europeanpharmaceuticalreview
April 08, 2020
An open letter from doctors highlights that although chloroquine and hydroxychloroquine are strong candidates to fight COVID-19, there is a limited supply.
Positive results from initial lopinavir-ritonavir COVID-19 clinical trial europeanpharmaceuticalreview
April 08, 2020
Researchers found that the combination of lopinavir-ritonavir HIV antivirals led to rapid symptom improvement in COVID-19 patients.
Pharma sales to increasingly rely on virtual platforms due to COVID-19, says report europeanpharmaceuticalreview
April 08, 2020
Virtual tools are being increasingly utilised by pharma companies to replace in-person meetings following the outbreak of the COVID-19 pandemic.
OncoSec Collaborates with Providence Cancer Institute contractpharma
April 08, 2020
To conduct first-in-human trial of OncoSec's CORVax12, an investigational vaccine to prevent COVID-19.
Applied Biology to Launch COVID-19 Drug Discovery Platform contractpharma
April 08, 2020
Based on breakthrough discovery made in collaboration with Brown University researchers.
Hope Bio Gets FDA Nod to Start First Stem Cell COVID-19 Clinical Trial contractpharma
April 08, 2020
Autologous mesenchymal stem cells to provide immune support against COVID-19.
Almac Offers Expedited Support for COVID-19 Clinical Trials contractpharma
April 08, 2020
Expedited implementation of Interactive Response Technology (IRT) in support of pandemic research efforts.
Inovio commences Phase I trial of DNA vaccine for Covid-19 pharmaceutical-technology
April 08, 2020
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
Drug supply chain disruptions due to COVID-19 a very high concern: Poll pharmaceutical-technology
April 08, 2020
Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that 90% are either highly or partially concerned about the disruption.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page